Product Leaflet: Atomoxetine
Date of Initial Approval: Exchange Tower October 31, 2007 130 King Street West, Suite 900 PO Box 73 Date of Revision: Toronto, Ontario March25, 2021
PRODUCT MONOGRAPH PrTEVA-ATOMOXETINE (atomoxetine capsules) 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg and 100 mg atomoxetine (as atomoxetine
Manufacturer’s standard
5 hours in adult patients
Selective Norepinephrine Reuptake Inhibitor for attention-deficit / Hyperactivity Disorder (ADHD) STRATTERA(r) Product Monograph contains health professional information, indications and contraindications, warnings and
atomoxetine + iobenguane I 131 D/C atomoxetine for at least 5 half-lives before admin
feeling of warmth, redness of the face, neck, arms, and occasionally, upper chest
Uses for Atomoxetine Attention Deficit Hyperactivity Disorder
Pediatric
2 mg/kg/day; may administer either once daily in the morning or in 2 evenly divided doses and administered in the morning and late afternoon/early evening; maximum daily dose: 1
8 mg/mL in water
1 The global incidence of ADHD in children (ie, less than 18 years of age) ranges between 5
fainting
4% of children—that translates to 1 in every 250 children—started thinking about suicide in the first 12 weeks of treatment
Atomoxetine (brand name Strattera) is a non-stimulant drug used in the treatment of attention-deficit hyperactivity disorder (ADHD)
com
There is no published experience with atomoxetine during breastfeeding, although reports from the manufacturer found no serious adverse effects in two breastfed infants
In the clinical development program, seizures were reported on 0
Atomoxetine can interact with certain antidepressants, albuterol, and medications that raise blood pressure